1. Home
  2. SCNI vs CETX Comparison

SCNI vs CETX Comparison

Compare SCNI & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • CETX
  • Stock Information
  • Founded
  • SCNI 2003
  • CETX 1998
  • Country
  • SCNI Israel
  • CETX United States
  • Employees
  • SCNI N/A
  • CETX N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • CETX EDP Services
  • Sector
  • SCNI Health Care
  • CETX Technology
  • Exchange
  • SCNI Nasdaq
  • CETX Nasdaq
  • Market Cap
  • SCNI 1.9M
  • CETX 1.6M
  • IPO Year
  • SCNI N/A
  • CETX 1998
  • Fundamental
  • Price
  • SCNI $2.55
  • CETX $0.92
  • Analyst Decision
  • SCNI
  • CETX
  • Analyst Count
  • SCNI 0
  • CETX 0
  • Target Price
  • SCNI N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • SCNI 1.1M
  • CETX 1.1M
  • Earning Date
  • SCNI 07-01-2025
  • CETX 05-15-2025
  • Dividend Yield
  • SCNI N/A
  • CETX N/A
  • EPS Growth
  • SCNI N/A
  • CETX N/A
  • EPS
  • SCNI N/A
  • CETX N/A
  • Revenue
  • SCNI $658,000.00
  • CETX $73,816,291.00
  • Revenue This Year
  • SCNI N/A
  • CETX $19.77
  • Revenue Next Year
  • SCNI N/A
  • CETX $15.00
  • P/E Ratio
  • SCNI N/A
  • CETX N/A
  • Revenue Growth
  • SCNI N/A
  • CETX 12.93
  • 52 Week Low
  • SCNI $1.90
  • CETX $0.85
  • 52 Week High
  • SCNI $8.92
  • CETX $791.49
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 46.70
  • CETX 35.35
  • Support Level
  • SCNI $2.32
  • CETX $0.85
  • Resistance Level
  • SCNI $6.18
  • CETX $1.06
  • Average True Range (ATR)
  • SCNI 0.41
  • CETX 0.22
  • MACD
  • SCNI -0.01
  • CETX -0.08
  • Stochastic Oscillator
  • SCNI 8.10
  • CETX 3.52

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: